During the past decade, Group Health Research Institute conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 14 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Group Health Research Institute" #1 sponsor was "Kaiser Permanente" with 41 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials sponsored, "Pfizer" with 3 trials sponsored, "University of Washington" with 3 trials sponsored and "Fred Hutchinson Cancer Center" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Group Health Research Institute" #1 collaborator was "Kaiser Permanente" with 8 trials as a collaborator, "University of Washington" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 4 trials as a collaborator and "University of Michigan" with 4 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Group Health Research Institute" are "Influenza" (7 trials), "Depression" (4 trials), "Obesity" (4 trials), "Smoking" (4 trials) and "Dementia" (3 trials). Many other conditions were trialed in "Group Health Research Institute" in a lesser frequency.

Most popular intervention types in "Group Health Research Institute" are "Behavioral" (38 trials), "Biological" (19 trials), "Other" (18 trials), "Drug" (12 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "13vPnC" (2 trials), "20vPnC" (2 trials), "PPSV23" (2 trials) and "Trivalent inactivated influenza vaccine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Group Health Research Institute" are 59 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are 10 active trials in "Group Health Research Institute". 1 are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in Group Health Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Group Health Research Institute, 7 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 41 trials that are defined as “Not Applicable".

Group Health Research Institute has several departments that took part in Clinical trials: "Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases" - 15 trials